By improving DDR, GLP-1 RAs may limit the build-up of DNA damage, which in turn diminishes cellular aging and enhances tolerance to cellular stress
This creates a dangerous bottleneck where highly toxic Phase I intermediates accumulate in the liver, leading to systemic toxicity, severe hepatic inflammation, and a cascading failure of the body's natural waste-removal systems
The most common side effects are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and reduced appetite
Differences in dosing schedules, potency, receptor affinity, and pharmacokinetic profiles help explain these variations in clinical outcomes
GHK-Cu is not approved for human or veterinary use by any regulatory agency
Eliminacin de residuos: Adems, desempea un papel clave en la limpieza de subproductos txicos derivados del metabolismo celular